Genetic imbalances with impact on survival in colorectal cancer patients

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Histopathology

• Publication date

  2003-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2559.2003.01720.xPMID 14511250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in Brief Comparative Genomic in Situ Hybridization of Colon Carcinomas with Replication Error '

  2006cited by this paper
• Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas

  2004influential reference
• The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

  2002cited by this paper
• Similar patterns of genomic alterations characterize primary mediastinal large‐B‐cell lymphoma and diffuse large‐B‐cell lymphoma

  2002cited by this paper
• Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases

  2002influential reference
• Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer

  2001cited by this paper
• Genomic alterations in malignant transformation of Barrett's esophagus.

  2001cited by this paper
• Chromosomal aberrations in colorectal cancers and liver metastases analyzed by comparative genomic hybridization

  2001cited by this paper
• Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

  2001cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer

  2000cited by this paper
• MYB oncogene amplification in hereditary BRCA1 breast cancer.

  2000cited by this paper
• [Adjuvant therapy for colon cancer].

  2000cited by this paper
• Chromosomal Imbalances in Brain Metastases of Solid Tumors

  2000cited by this paper
• New adjuvant therapy for colon cancer: justified hope or commercial hype.

  2000cited by this paper
• Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases

  1999cited by this paper
• Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization

  1999cited by this paper
• Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability

  1999cited by this paper
• Aberrant rel/nfkb genes and activity in human cancer

  1999cited by this paper
• Tracking recurrent quantitative genomic alterations in colorectal cancer: allelic losses in chromosome 4 correlate with tumor aggressiveness.

  1999cited by this paper
• Deletion mapping of the tumor suppressor locus involved in colorectal cancer on chromosome band 8p21

  1999cited by this paper
• Assignment1 of cadherin-4 (R-cadherin, CDH4) to human chromosome band 20q13.3

  1999cited by this paper
• Adjuvant therapy of colon cancer

  1999cited by this paper
• Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer

  1999cited by this paper
• Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer.

  1998cited by this paper
• Genetic instabilities in human cancers

  1998cited by this paper
• Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract.

  1998cited by this paper
• Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals.

  1998cited by this paper
• Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.

  1998cited by this paper
• Molecular prognostic markers and colorectal cancer: the search goes on.

  1998cited by this paper
• Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung.

  1997influential reference
• A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines

  1997cited by this paper
• Prognostic value of chromosome 1p allelic loss in colon cancer.

  1997cited by this paper
• A t-statistic for objective interpretation of comparative genomic hybridization (CGH) profiles.

  1997cited by this paper
• Mad-related genes in the human

  1996cited by this paper
• Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors

  1996cited by this paper
• Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers

  1996cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

  1996cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• Comparative genomic in situ hybridization of colon carcinomas with replication error.

  1995cited by this paper
• Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

  1995cited by this paper
• Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.

  1995cited by this paper
• Allelic loss of chromosome 18q and prognosis in colorectal cancer.

  1994cited by this paper
• The Molecular Basis of Kindling

  1993cited by this paper
• Current status of adjuvant chemotherapy for colorectal cancer: Can molecular markers play a role in predicting prognosis?

  1992cited by this paper
• Metalloproteinases and their inhibitors in matrix remodeling.

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper

• RNA Binding Protein RNPC1 Promotes Gastric Cancer Progression via Stabilizing the Aurora Kinase B mRNA

  2021cites this paper
• RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing Aurora kinase B mRNA.

  2021cites this paper
• MTFR2 regulates mitochondrial fission and impacts spindle integrity during mitosis

  2020cites this paper
• Genomic approach to translational studies in colorectal cancer

  2018cites this paper
• Copy number alterations in colorectal cancer

  2016cites this paper
• RNA-binding protein RBM 38 : acting as a tumor suppressor in colorectal cancer

  2016cites this paper
• Integrative genomic analyses of the RNA-binding protein, RNPC1, and its potential role in cancer prediction.

  2015cites this paper
• Tumors of the Digestive Tract

  2015cites this paper
• Identification of a characteristic copy number alteration profile by high‐resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer

  2014cites this paper
• Significant Evidence of Linkage for a Gene Predisposing to Colorectal Cancer and Multiple Primary Cancers on 22q11

  2014cites this paper
• RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer

  2014cites this paper
• Hypoxia-inducible factor 1 alpha is regulated by RBM38, a RNA-binding protein and a p53 family target, via mRNA translation

  2014cites this paper
• An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort

  2013cites this paper
• Deletion and Down-Regulation of HRH4 Gene in Gastric Carcinomas: A Potential Correlation with Tumor Progression

  2012cites this paper
• BRAF V600E mutated colon carcinoma associated genomic profile differs from double wild type tumors genome

  2012cites this paper
• A Genome-Wide Study of Cytogenetic Changes in Colorectal Cancer Using SNP Microarrays: Opportunities for Future Personalized Treatment

  2012cites this paper
• Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas.

  2011cites this paper
• Dukes stage B colorectal cancers analysed with array comparative genomic hybridisation

  2011cites this paper
• Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients

  2011cites this paper
• Epithelial vanin‐1 controls inflammation‐driven carcinogenesis in the colitis‐associated colon cancer model

  2010cites this paper
• Epidemiology And Risk Factors In Carcinomas Of The Large Bowel

  2010cites this paper
• Deletion of Chromosome 4q Predicts Outcome in Stage II Colon Cancer Patients

  2010cites this paper
• Chromosomal instability in sporadic colorectal cancer

  2009cites this paper
• Untersuchung von Cytokeratinprofilen und ihrer prognostischen Relevanz bei kolorektalen Karzinomen - Eine TMA Untersuchung an 2919 Gewebeproben

  2008cites this paper
• Chromosomale Signaturen und Immunprofile in der Tumorprogression kolorektaler Karzinome

  2007cites this paper
• Genetic abnormalities involved in t(12;21) TEL–AML1 acute lymphoblastic leukemia: Analysis by means of array‐based comparative genomic hybridization

  2007cites this paper
• Relationship between chromosome 18q status and colorectal cancer prognosis: a prospective, blinded analysis of 280 patients.

  2007cites this paper
• Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization.

  2006cites this paper
• Molecular Cytogenetics: Genomic Imbalances in Colorectal Cancer and their Clinical Impact

  2006cites this paper
• A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer

  2006influential citation
• Cytokeratin Profiles Identify Diagnostic Signatures in Colorectal Cancer Using Multiplex Analysis of Tissue Microarrays

  2006cites this paper
• CtIP, a Multivalent Adaptor Connecting Transcriptional Regulation, Checkpoint Control and Tumor Suppression

  2006cites this paper
• The order of genetic events associated with colorectal cancer progression inferred from meta‐analysis of copy number changes

  2006cites this paper
• Meta-analysis and pooled re-analysis of copy number changes in colorectal cancer detected by comparative genomic hybridization.

  2006cites this paper
• MICROARRAYS AND OTHER NEW TECHNOLOGIES Recurrent Genomic Alterations With Impact on Survival in Colorectal Cancer Identified by Genome-Wide Array Comparative Genomic Hybridization

  2006cites this paper
• Estado actual del valor pronóstico de los marcadores moleculares en pacientes con cáncer colorrectal y la predicción de respuesta al tratamiento adyuvante

  2005cites this paper
• Fractional Genomic Alteration Detected by Array-Based Comparative Genomic Hybridization Independently Predicts Survival after Hepatic Resection for Metastatic Colorectal Cancer

  2005cites this paper
• [Current status of the prognostic value of molecular markers in patients with colorectal cancer and the prediction of response to adjuvant therapy].

  2005cites this paper
• The PCNA-associated factor KIAA0101/p15(PAF) binds the potential tumor suppressor product p33ING1b.

  2005cites this paper
• A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis.

  2005influential citation
• Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer.

  2005cites this paper
• Identification of a Novel Homozygous Deletion Region at 6q23.1 in Medulloblastomas Using High-Resolution Array Comparative Genomic Hybridization Analysis

  2005cites this paper
• Chromosomal Alterations in Lung Metastases of Colorectal Carcinomas: Associations with Tissue Specific Tumor Dissemination

  2005cites this paper
• Identification and characterization of human FHDC1, mouse Fhdc1 and zebrafish fhdc1 genes in silico.

  2004cites this paper